We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.52B
AUM Growth
+$72.5M
Cap. Flow
-$111M
Cap. Flow %
-7.32%
Top 10 Hldgs %
40.87%
Holding
162
New
22
Increased
37
Reduced
54
Closed
28

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$25.8M
2
AB icon
AllianceBernstein
AB
+$20.1M
3
HES
Hess
HES
+$17.1M
4
BIDU icon
Baidu
BIDU
+$16.3M
5
TGTX icon
TG Therapeutics
TGTX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.94%
2 Consumer Discretionary 9.33%
3 Financials 7.76%
4 Industrials 6.88%
5 Materials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECXWW
126
ECARX Holdings Warrants
ECXWW
$7.41K ﹤0.01%
125,000
APLMW icon
127
Apollomics Inc Warrant
APLMW
$1.37M
$5.76K ﹤0.01%
130,000
MSAIW icon
128
MultiSensor AI Holdings Warrant
MSAIW
$705K
$4.84K ﹤0.01%
150,000
IMTXW
129
DELISTED
Immatics N.V. Warrants
IMTXW
$209 ﹤0.01%
348,032
AB icon
130
AllianceBernstein
AB
$3.46B
-525,825
Closed -$20.1M
AFMD
131
DELISTED
Affimed
AFMD
-654,600
Closed -$473K
AGRO icon
132
Adecoagro
AGRO
$1.37B
-474,103
Closed -$5.3M
BIDU icon
133
Baidu
BIDU
$38.3B
-177,500
Closed -$16.3M
CZR icon
134
PUT
Caesars Entertainment
CZR
$6.06B
-50,000
Closed -$1.25M
DHT icon
135
DHT Holdings
DHT
$2.98B
-150,000
Closed -$1.57M
LKFT
136
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
-110,100
Closed -$2.77M
HES
137
DELISTED
Hess
HES
-107,295
Closed -$17.1M
IOVA icon
138
Iovance Biotherapeutics
IOVA
$1.93B
-2,400,000
Closed -$7.99M
ITOS
139
DELISTED
iTeos Therapeutics
ITOS
-1,750,000
Closed -$10.4M
KBR icon
140
CALL
KBR
KBR
$4.68B
-100,000
Closed -$4.98M
KBR icon
141
KBR
KBR
$4.68B
-131,000
Closed -$6.53M
KBR icon
142
PUT
KBR
KBR
$4.68B
-100,000
Closed -$4.98M
LDOS icon
143
CALL
Leidos
LDOS
$14.9B
-48,800
Closed -$6.59M
LDOS icon
144
Leidos
LDOS
$14.9B
-43,000
Closed -$5.8M
LDOS icon
145
PUT
Leidos
LDOS
$14.9B
-48,800
Closed -$6.59M
MTA
146
Metalla Royalty & Streaming
MTA
$701M
-109,080
Closed -$315K
NUVB.WS
147
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
-335,754
Closed -$107K
PDD icon
148
Pinduoduo
PDD
$128B
-95,000
Closed -$11.2M
PDLB icon
149
Ponce Financial Group
PDLB
$496M
-55,000
Closed -$697K
SAIC icon
150
CALL
Saic
SAIC
$5.08B
-50,000
Closed -$5.61M

Similar funds

683 Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, 683 Capital Management held 162 positions worth $1.52B, up 5% from $1.45B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

683 Capital Management withdrew a net $111M in Q2 2025, closing 28 positions and reducing 54 holdings. Its most notable exit was AllianceBernstein, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Barrick Mining worth $28.6M.

  • 683 Capital Management's largest Q2 2025 buy was Barrick Mining: 1,375,000 shares worth $28.6M.
  • 683 Capital Management added most to Sarepta Therapeutics in Q2 2025, an estimated $21.8M increase.
  • 683 Capital Management's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $25.8M.
  • 683 Capital Management fully exited AllianceBernstein in Q2 2025, selling an estimated $20.1M.
  • 683 Capital Management's ten largest holdings make up 41% of its $1.52B portfolio in Q2 2025.
  • 683 Capital Management opened 22 new positions and closed 28 in Q2 2025.
  • 683 Capital Management's portfolio value rose 5% quarter-over-quarter to $1.52B.

Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.